Physician profile
Jay M Snow
NPI 1003956418
$4,734.61
in general payments reported to CMS, 2019-2025
14 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,877 · 2020: $326 · 2021: $103 · 2022: $211 · 2023: $247 · 2024: $759 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160 · Travel and Lodging: $58.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.89 |
| Travel and Lodging | $58.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $2,833.00 | 2019-2020 | |
| Medtronic, INC. | $474.40 | 2021-2024 | Signia, Appose Ulc, Sonicision |
| Ethicon US, LLC | $470.17 | 2020-2025 | Echelon Endopath, Echelon; Endopath, Echelon Flex |
| W. L. Gore & Associates, INC. | $377.06 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard |
| Stryker Corporation | $159.22 | 2023 | Spy-Phi System |
| Covidien Lp | $126.69 | 2019 | |
| Novo Nordisk INC | $74.14 | 2022-2025 | Wegovy |
| Conmed Corporation | $47.49 | 2025 | Airseal |
| Boston Scientific Corporation | $38.95 | 2025 | Overstitch Endoscopic Suturing System |
| Smith+Nephew, INC. | $34.81 | 2023 | Pico 14 |
| Lilly USA, LLC | $33.69 | 2024 | Zepbound |
| Redhill Biopharma INC. | $22.64 | 2021 | |
| Ambu INC. | $21.26 | 2024 | |
| Eagle Pharmaceuticals, INC. | $21.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.